Ammonium sulphate precipitation to measure antibodies to double-stranded DNA: A simple clinical test for diagnosis and management of patients with systemic lupus erythematosus

Lupus

Volumn 18, Issue 14, 2009, Pages 1243-1245

  Pincus, T ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM SULFATE; ANTINUCLEAR ANTIBODY; DNA;

ARTICLE; HISTORY; HUMAN; IMMUNOLOGY; IMMUNOPRECIPITATION; IMMUNORADIOMETRIC ASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMMONIUM SULFATE; ANTIBODIES, ANTINUCLEAR; DNA; HISTORY, 20TH CENTURY; HUMANS; IMMUNOPRECIPITATION; IMMUNORADIOMETRIC ASSAY; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 74049162066     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309106768     Document Type: Article

References (20)

1. Seligmann M. Serologie - mise en evidence dan le serum des malades atteints de Lupus erythemateux, dissemine d’une substance determinant une reaction de precipitation avec l’acide desoxyribonucleique. Compt Rend Acad Sci (Paris) 1957; 245: 243-245.
2. Ceppellini R., Polli E., Celada F. A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exp Biol Med 1957; 96: 572-574.
3. Robbins WC, Holman HR, Deicher H., Kunkel HG Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med 1957; 96: 575-579.
4. Pincus T., Haberkern R., Christian CL Experimental chronic glomerulitis. J Exp Med 1968; 127: 819-832.
5. Pincus T., Schur PH, Rose JA, Decker JL, Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med 1969; 281: 701-705.
6. Pincus, T. Citation Classic [ Pincus, T., Schur, P.H., Rose, J.A., Decker, J.L., Talal, N., measurement of serum DNA-binding in activity in systemic lupus erythematosus. N Eng J Med 281: 701-705, 1969.]. Current Contents - Clinical Practice 1983; 11: 18.
7. Steinberg AD, Raveche ES, Laskin CA, Miller ML, Steinberg RT Genetic, environmental, and cellular factors in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 734-743.
8. Lightfoot Jr RW, Hughes GRV Significance of persisting serologic abnormalities in SLE. Arthritis Rheum 1976; 19: 837-843.
9. Pincus T., Hartley JW, Rowe WP A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J Exp Med 1971; 133: 1219-1233.
10. Alberto BP, Callahan LF, Pincus T. Evidence that retrovirus expression in mouse spleen cells results from B cell differentiation. J Immunol 1982; 129: 2768-2772.
11. Pincus T., Blacklow NR, Grimley PM, Bellanti JA Glomerular microtubules of systemic lupus erythematosus. Lancet 1970; 2: 1058-1061.
12. Pincus T., Steinberg AD, Blacklow NR, Decker JL Reactivities of systemic lupus erythematosus sera with cellular and virus antigen preparations. Arthritis Rheum 1978; 21: 873-879.
13. Pincus T. Studies regarding a possible function for viruses in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 847-856.
14. Pincus T., Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984; 27: 864-872.
15. Pincus T., Bergman MJ, Yazici Y., Hines P., Raghupathi K., Maclean R. An index of on ly patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford) 2008; 47: 345-349.
16. Pincus T. Pain, function, and RAPID scores - vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health. Bull NYU Hosp Jt Dis 2008; 66: 155-165.
17. Pincus T., Sokka T. Can a multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID) scores be informative in patients with all rheumatic diseases? Best Pract Res Clin Rheumatol 2007; 21: 733-753.
18. Pincus T., Wolfe F. Patient questionnaires for clinical research and improved standard patient care: is it better to have 80% of the information in 100% of patients or 100% of the information in 5% of patients? J Rheumatol 2005; 32: 575-577.
19. Pincus T., Sokka T., Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005; 52: 1009-1019.
20. Thomas L. The lives of a cell: notes of a biology-watcher. New York: Viking Press; 1974.